Atlas Venture is a US-based venture capital firm specializing in early-stage investments in technology and life science companies. The firm typically participates in Seed, Series A, and Series B rounds, supporting startups with significant potential for innovation and growth. Atlas Venture's focus is on translating groundbreaking science into life-changing medicines, partnering with top-tier life science entrepreneurs to create and build breakthrough biotech companies.

Notable portfolio companies include Alnylam Pharmaceuticals, DraftKings, Intellia Therapeutics, and PillPack. Key partners at Atlas Venture bring extensive industry experience and have been affiliated with successful ventures across the biotech and tech sectors. The firm's investment philosophy centers on fostering deep collaborations with entrepreneurs to drive impactful advancements. Atlas Venture also offers unique value-add services, including strategic guidance, operational support, and access to a robust network of industry experts and resources.